Clinical trial

Molecular Profiling in Lung Cancer Patients

NCT00191308

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-05-01

PhasePHASE2

Study timeline

Study start (unknown)2005-05-01Date precision: month

Registry last updated2011-10-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small Cell Lung Cancerunresolved

Carcinomaunresolved

Interventions

pemetrexedDRUG · verified · RxNorm: pemetrexed

cisplatinDRUG · verified · RxNorm: cisplatin

Radical Non-Small Cell Lung Cancer (NSCLC) surgeryPROCEDURE

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

WarsawPoland1 PoznanPoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00191308 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.